0.75
-0.0501 (-6.26%)
-0.0501 (-6.26%)
Upgrade to Real-Time
Afterhours
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Outlook Therapeutics Inc | OTLK | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.0501 | -6.26% | 0.75 | 16:38:06 |
| Close Price | Low Price | High Price | Open Price | Previous Close |
|---|---|---|---|---|
| 0.76 | 0.73 | 0.8037 | 0.8037 | 0.8001 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 0.75 | 0.7999 | 0.0499 | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,316 | 369,206 | $ 0.7588377 | $ 280,167 | 936,841 | 0.4011 - 1.74 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:46:46 | 5 | $ 0.75 | USD |
Outlook Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 95.39M | 127.18M | 105.54M | $ 8.15M | $ - | -2.42 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Outlook Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical OTLK Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.90 | 0.90 | 0.69 | 0.7910172 | 614,240 | -0.15 | -16.67% |
| 1 Month | 0.67 | 0.93 | 0.6605 | 0.8020072 | 878,835 | 0.08 | 11.94% |
| 3 Months | 1.39 | 1.60 | 0.58 | 0.975081 | 2,142,148 | -0.64 | -46.04% |
| 6 Months | 0.6795 | 1.73 | 0.58 | 1.15 | 2,362,323 | 0.0705 | 10.38% |
| 1 Year | 1.23 | 1.74 | 0.4011 | 1.09 | 1,550,948 | -0.48 | -39.02% |
| 3 Years | 5.60 | 20.00 | 0.4011 | 1.81 | 1,620,139 | -4.85 | -86.61% |
| 5 Years | 5.60 | 20.00 | 0.4011 | 1.81 | 1,620,139 | -4.85 | -86.61% |
Outlook Therapeutics Description
| Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. |
